Skip to content
DraconiticResearch
Search Sources API
197,788 studies31 sourcesUpdated 1 h ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

Single-cell transcriptomics uncovers persistent hepatic immunometabolic remodeling following SARS-CoV-2 infection in obese hosts

  • Wei Qian1
  • Xiaoqin Wei1
  • Soo-Jeung Park1
  • Josefina Garcia Diaz1,2
  • Tina Comlekoglu1
  • Jane Yu1,3
  • Jie Sun1,3
  • Young S. Hahn1,2
  1. 1Beirne B. Carter Center for Immunology Research, University of Virginia
  2. 2Department of Microbiology, Immunology and Cancer Biology, University of Virginia
  3. 3Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia
Read full textPDFDOICite

Abstract

SARS-CoV-2 infection affects multiple organs, and chronic post-viral tissue injury is often associated with persistent immune dysregulation. Obesity and related metabolic disorders are major risk factors for severe COVID-19 and post-acute sequelae of SARS-CoV-2 infection (PASC), including liver dysfunction. To define hepatic responses during post-acute infection, we studied lean and diet-induced obese mice at 7 and 28 days following infection with mouse-adapted SARS-CoV-2. Compared with lean mice, obese mice exhibited persistent lung inflammation and fibrosis, along with liver injury characterized by increased lipid accumulation, cellular apoptosis, and metabolic dysfunction. Single-cell RNA sequencing revealed obesity-associated alterations in hepatic immune and metabolic programs during post-acute infection. In particular, hepatic macrophages in obese mice showed sustained inflammatory and metabolic transcriptional alterations, while hepatocytes displayed altered programs associated with gluconeogenesis and lipid metabolism. Endothelial cells also exhibited persistent transcriptional changes linked to immune activation and prothrombotic pathways. These alterations remained evident at 28 days post-infection, suggesting incomplete restoration of immune and metabolic homeostasis in obese liver. Collectively, our findings reveal persistent obesity-associated hepatic immunometabolic remodeling following SARS-CoV-2 infection and identify cellular and molecular programs that may contribute to post-acute liver sequelae in metabolically compromised hosts.

Related

  1. Persistent Pelvic Adhesions and Fibrotic Remodeling Following Ectopic Lesion Ablation in a Mouse Model of Endometriosis
    Sohyeon Yun, Kyeong A. So, Eunhee M. Jeong +8
    The FASEB JournalPeer-reviewedCC BY-NC-ND 4.0Full textObstetrics, gynaecology & paediatricsPMCEurope PMC
  2. Dynamic remodeling of microglial responses in Alzheimer's disease: heterogeneous states, spatiotemporal progression, and immunometabolic dysregulation.
    Simin Han, Shanshan Wang, Jingjing Liu +3
    Frontiers in cell and developmental biologyPeer-reviewedCC BYFull textNeurologyEurope PMCPMC
  3. Lactylation-mediated remodeling of spatial immunometabolic niches in lung cancer: metabolic origins, cellular interactions, and molecular mechanisms
    Zihao Lin, Chengri Che, Shuwei Wang
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  4. Fatty acid dysregulation in asthma: linking immunometabolic remodeling, phenotypic heterogeneity, and metabolic precision medicine
    Yuan Yuan, Yunhao Peng
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textPhysiologyCrossrefEurope PMCPMCEurope PMC
  5. Inflammatory Burden Shapes Antioxidant Adaptation and Immunometabolic Remodeling in LPS-Activated BV-2 Microglial Cells
    Maria Cristina Barbalace, Irene Rinaldi, Martina Mantini +9
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textNeurologyCrossrefEurope PMC

Cite

BibTeXRIS
BibTeX
@article{qian2026singlecell,
  title = {{Single-cell transcriptomics uncovers persistent hepatic immunometabolic remodeling following SARS-CoV-2 infection in obese hosts}},
  author = {Wei Qian and Xiaoqin Wei and Soo-Jeung Park and Josefina Garcia Diaz and Tina Comlekoglu and Jane Yu and Jie Sun and Young S. Hahn},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.1910050},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1910050/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Single-cell transcriptomics uncovers persistent hepatic immunometabolic remodeling following SARS-CoV-2 infection in obese hosts
AU  - Wei Qian
AU  - Xiaoqin Wei
AU  - Soo-Jeung Park
AU  - Josefina Garcia Diaz
AU  - Tina Comlekoglu
AU  - Jane Yu
AU  - Jie Sun
AU  - Young S. Hahn
PY  - 2026
DA  - 2026/10/14
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1910050
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1910050/full
AB  - SARS-CoV-2 infection affects multiple organs, and chronic post-viral tissue injury is often associated with persistent immune dysregulation. Obesity and related metabolic disorders are major risk factors for severe COVID-19 and post-acute sequelae of SARS-CoV-2 infection (PASC), including liver dysfunction. To define hepatic responses during post-acute infection, we studied lean and diet-induced obese mice at 7 and 28 days following infection with mouse-adapted SARS-CoV-2. Compared with lean mice, obese mice exhibited persistent lung inflammation and fibrosis, along with liver injury characterized by increased lipid accumulation, cellular apoptosis, and metabolic dysfunction. Single-cell RNA sequencing revealed obesity-associated alterations in hepatic immune and metabolic programs during post-acute infection. In particular, hepatic macrophages in obese mice showed sustained inflammatory and metabolic transcriptional alterations, while hepatocytes displayed altered programs associated with gluconeogenesis and lipid metabolism. Endothelial cells also exhibited persistent transcriptional changes linked to immune activation and prothrombotic pathways. These alterations remained evident at 28 days post-infection, suggesting incomplete restoration of immune and metabolic homeostasis in obese liver. Collectively, our findings reveal persistent obesity-associated hepatic immunometabolic remodeling following SARS-CoV-2 infection and identify cellular and molecular programs that may contribute to post-acute liver sequelae in metabolically compromised hosts.
SN  - 1664-3224
ER  -